143 related articles for article (PubMed ID: 36326317)
81. Presence of endometrial adenocarcinoma in situ in complex atypical endometrial hyperplasia is associated with increased incidence of endometrial carcinoma in subsequent hysterectomy.
Mittal K; Sebenik M; Irwin C; Yan Z; Popiolek D; Curtin J; Palazzo J
Mod Pathol; 2009 Jan; 22(1):37-42. PubMed ID: 19116629
[TBL] [Abstract][Full Text] [Related]
82. NF-κB and COX-2 expression in nonmalignant endometrial lesions and cancer.
Faloppa CC; Baiocchi G; Cunha IW; Fregnani JH; Osorio CA; Fukazawa EM; Kumagai LY; Badiglian-Filho L; Pinto GL; Soares FA
Am J Clin Pathol; 2014 Feb; 141(2):196-203. PubMed ID: 24436266
[TBL] [Abstract][Full Text] [Related]
83. Risk of malignancies among asymptomatic postmenopausal women with thickened endometrium: A cohort study.
Li Z; Li L
Medicine (Baltimore); 2019 Feb; 98(6):e14464. PubMed ID: 30732213
[TBL] [Abstract][Full Text] [Related]
84. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
[TBL] [Abstract][Full Text] [Related]
85. Diagnostic methods of early detection of endometrial hyperplasia and cancer.
Pace S; Grassi A; Ferrero S; Figliolini N; Catania R; Labi FL; Pachì A; Figliolini M
Eur J Gynaecol Oncol; 1995; 16(5):373-81. PubMed ID: 8549603
[TBL] [Abstract][Full Text] [Related]
86. Endometrial brush cytology of advanced postmenopausal endometrium: does endometrial intraepithelial neoplasia exist in the absence of hyperplasia?
Maksem JA
Diagn Cytopathol; 1998 Nov; 19(5):338-43. PubMed ID: 9812226
[TBL] [Abstract][Full Text] [Related]
87. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
[TBL] [Abstract][Full Text] [Related]
88. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
89. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
[TBL] [Abstract][Full Text] [Related]
90. Current molecular aspects of the carcinogenesis of the uterine endometrium.
Inoue M
Int J Gynecol Cancer; 2001; 11(5):339-48. PubMed ID: 11737463
[TBL] [Abstract][Full Text] [Related]
91. Performance characteristics of the Indiana University Medical Center endometrial sampler (Tao Brush) in an outpatient office setting, first year's outcomes: recognizing histological patterns in cytology preparations of endometrial brushings.
Maksem JA
Diagn Cytopathol; 2000 Mar; 22(3):186-95. PubMed ID: 10680001
[TBL] [Abstract][Full Text] [Related]
92. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
[TBL] [Abstract][Full Text] [Related]
93. [Conservative treatment of endometrial cancer and atypical hyperplasia].
Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
[TBL] [Abstract][Full Text] [Related]
94. [Pathologic diagnosis of the endometrial intraepithelial neoplasia].
Hui YZ
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):228-30. PubMed ID: 18844030
[No Abstract] [Full Text] [Related]
95. Benign and Premalignant Lesions of the Endometrium.
Mallinger WD; Quick CM
Surg Pathol Clin; 2019 Jun; 12(2):315-328. PubMed ID: 31097106
[TBL] [Abstract][Full Text] [Related]
96. [Conservative treatments for endometrial cancer].
Eid M; Gonthier C; Bucau M; Koskas M
Rev Prat; 2022 Sep; 72(7):747-749. PubMed ID: 36511962
[TBL] [Abstract][Full Text] [Related]
97. Endometrial cancer: improving management among increasing incidence rates.
eBioMedicine
EBioMedicine; 2024 May; 103():105159. PubMed ID: 38749574
[No Abstract] [Full Text] [Related]
98. Endometrial Cancer in Brazil: Preparing for the Rising Incidence.
Paulino E; Nogueira-Rodrigues A; Goss PE; Faroni L; Guitmann G; Strasser-Weippl K; Bukowski A
Rev Bras Ginecol Obstet; 2018 Oct; 40(10):577-579. PubMed ID: 30352454
[No Abstract] [Full Text] [Related]
99. BRCA1/2 and Endometrial Cancer Risk: Implications for Management.
Sherman ME; Foulkes WD
J Natl Cancer Inst; 2021 Sep; 113(9):1127-1128. PubMed ID: 33710310
[No Abstract] [Full Text] [Related]
100. Conservative management of patients with endometrial intraepithelial neoplasia (EIN): Factors that could affect response and pregnancy rates.
Iavazzo C; Gkegkes ID
Turk J Med Sci; 2022 Jun; 52(3):870. PubMed ID: 36326317
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
